Recordati SpA: Efficiency or Extraction?

  recordati-spa-efficiency-or-extraction.html
  Business and Finance on Tue, Oct 20th, 2026 by Hubert Carizone
      Locale: ITALY

The Recordati Tug-of-War: Efficiency or Extraction?

The ongoing conflict surrounding Recordati SpA has evolved from a mere boardroom disagreement into a flagship case study for the frictions inherent in modern corporate finance. At the heart of the matter is the accusation of "self-dealing," a term that suggests private equity (PE) firms are no longer content with simply growing a company, but are instead engineering scenarios that prioritize the fund's internal rate of return (IRR) over the actual health of the business they manage.

From a purely factual standpoint, the situation at Recordati highlights a recurring pattern in the PE playbook. When a private equity firm takes a significant stake in a pharmaceutical entity, the goal is usually a predictable exit strategy. However, when the interests of the PE firm diverge from those of minority shareholders, the mechanisms used to extract value—such as aggressive dividend recapitalizations or steering contracts toward other portfolio companies—can look less like strategic management and more like a systematic draining of assets. The Bloomberg analysis suggests that the Recordati fight is a symptom of a broader problem: the lack of oversight regarding how PE firms manage conflicts of interest when they occupy both the role of owner and advisor.

I remember talking to a former compliance officer from a similar European pharma deal a few years back. He described the atmosphere as "clinical." He noted how the PE managers didn't talk about patients or long-term ®&D, but rather about "unlocking value" in a way that felt more like dismantling a clock than fixing one. That clinical detachment is precisely what critics of the Recordati arrangement are pointing to. The human cost is often ignored in the spreadsheets, but the tension in the halls of a company like Recordati—which has deep roots and a specific corporate identity—becomes palpable when the new owners treat it as a disposable asset.

However, it is necessary to provide an opposing view to the "self-dealing" narrative. What critics call self-dealing, proponents of private equity call capital discipline. The argument here is that public markets, or traditional family-led management, can often become bloated and inefficient. PE firms bring a level of rigor and accountability that forces companies to trim waste and focus on high-margin activities. In this view, the actions taken at Recordati are not an act of predation, but a necessary correction to ensure the company remains competitive in a brutal global pharmaceutical market.

Furthermore, the accusation of self-dealing often ignores the risk profile assumed by the PE firm. They are not passive investors; they deploy massive amounts of capital and provide strategic guidance that a stagnant board might never consider. If the PE firm seeks a return that appears aggressive, it is because they have priced in the risk of the investment. The "conflict of interest" is, in reality, the fundamental nature of the contract: the PE firm is hired to maximize value. If they use their ecosystem of other portfolio companies to create synergies, it is not self-dealing, but rather an optimization of the supply chain.

There is also the question of governance. If the minority shareholders and the board agreed to the terms of the PE entry, then the current friction is less about "problems" with PE and more about the inherent risks of the deals they signed. Their are always trade-offs when choosing between the slow growth of traditional management and the high-velocity growth associated with private equity.

Ultimately, the Recordati SpA fight serves as a mirror reflecting two different philosophies of capitalism. One sees the corporation as a long-term institution that serves a variety of stakeholders, while the other sees it as a financial instrument to be optimized and liquidated. Whether this constitutes a "problem" or simply the way the modern world works depends entirely on whether you are the one holding the spreadsheet or the one working in the lab.